LifeVantage Corporation Announces Final Results of Self Tender Offer

LifeVantage Corporation Announces Final Results of Self Tender Offer

SALT LAKE CITY, Oct. 31, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, today announced the final results of its modified Dutch
auction tender offer for up to $40 million in value of its common stock, which
expired at 5:00 p.m., New York City time, on Friday, October 25, 2013. In
accordance with the terms and conditions of the tender offer, the Company has
accepted for purchase an aggregate of 16,326,530 shares of its common stock at
a purchase price of $2.45 per share, for an aggregate cost of approximately
$40 million. These shares represent approximately 13.9% of the Company's
outstanding shares of common stock as of September 13, 2013.

The depositary informed the Company that 20,026,222 shares of the Company's
common stock were properly tendered and not properly withdrawn at the purchase
price of $2.45 per share. Because more than $40 million in value of common
stock was properly tendered and not properly withdrawn, the tender offer was
oversubscribed.As a result, pursuant to the terms of the tender offer, shares
will be accepted on a pro rata basis.The final proration factor for the
tender offer is approximately 81.53%.The Company will promptly pay for the
shares accepted for purchase, and any shares tendered and not purchased will
be returned to tendering shareholders promptly thereafter.

D.A. Davidson & Co. was the dealer manager for the tender offer.Georgeson
Inc. was the information agent for the tender offer and Computershare was the
depositary for the tender offer. All inquiries about the tender offer should
be directed to Georgeson Inc. toll-free at (866)482‑4931.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker
of Protandim^®, the Nrf2 Synergizer^® patented dietary supplement,
TrueScience^® Anti-Aging Cream and LifeVantage® Canine Health, is a science
based network marketing company. LifeVantage is dedicated to visionary science
that looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level.
LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.

Forward Looking Statements

This press release contains forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995. Words and expressions reflecting optimism, satisfaction or
disappointment with current prospects, as well as words such as "believe,"
"hopes," "intends," "estimates," "expects," "projects," "plans,"
"anticipates," "look forward to" and variations thereof, identify
forward-looking statements, but their absence does not mean that a statement
is not forward-looking. Such forward-looking statements are not guarantees of
performance and LifeVantage's actual results could differ materially from
those contained in such statements. These forward-looking statements are based
on LifeVantage's current expectations and beliefs concerning future events
affecting LifeVantage and involve known and unknown risks and uncertainties
that may cause LifeVantage's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks and
uncertainties include, among others, those discussed in LifeVantage's Annual
Report on Form 10-K under the caption "Risk Factors," and in other documents
filed by LifeVantage from time to time with the SEC. LifeVantage cautions
investors not to place undue reliance on the forward-looking statements
contained in this document. All forward-looking statements are based on
information currently available to LifeVantage on the date hereof, and
LifeVantage undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of this document,
except as required by law.

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         -or-
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
 
Press spacebar to pause and continue. Press esc to stop.